Clinical Trial Results:
Estudio aleatorizado, multicéntrico, doble ciego, comparativo, exploratorio y controlado con placebo en fase II con FOLFIRI en combinación con MSC1936369B o placebo, con una "safety run-in part", como segunda linea de tratamiento en pacientes con cáncer colorrectal metastásico con k-ras mutado
A double-blind, randomized, comparative, multicenter, exploratory, and placebo-controlled Phase II trial of FOLFIRI plus MSC1936369B or placebo with a safety run-in part as second-line treatment of metastatic K Ras mutated colorectal cancer subjects
Summary
|
|
EudraCT number |
2009-015621-36 |
Trial protocol |
ES BE IT |
Global completion date |
25 May 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Nov 2016
|
First version publication date |
17 Nov 2016
|
Other versions |
|
Summary report(s) |
2011-002389-19_EudraCT DIsclosure Synopsis.pdf |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.